Follicular Lymphoma Progress in 2024

Posted on: Mar 03, 2025

Play Episode

Also available on

Description

This event will not be live streamed. You can submit your questions in advance by clicking the button "Notify when available"

At the American Society of Hematology (ASH) Conference in 2024, follicular lymphoma experts from all over the world presented on research and advancements in the field. Listen to this podcast with Dr. Carla Casulo and Judith Trotman to hear about some of the most exciting advancements for follicular lymphoma.

Overview

Listen to this podcast with Dr. Carla Casulo and Judith Trotman to hear about some of the most exciting advancements for follicular lymphoma from the 2024 ASH Conference.

ASH News Articles:

What is ASH? https://healthtree.org/follicular-lymphoma/community/articles/what-is-the-ash-conference-dlbcl

FL Specialist Insights https://healthtree.org/follicular-lymphoma/community/articles/ash-24-fl-specialists-insights-new-treatments

Best of ASH 2024: https://healthtree.org/follicular-lymphoma/community/articles/ash-24-the-best-of-it-all

ASH Videos:

https://healthtree.org/blood-cancer/university/courses/klLCY3gkYKWHQDry3bkZ

Let me know your thoughts on today's episode! Feel free to email me with questions, comments, or insights at hannah@healthtree.org.

On this episode

Hannah Loosle

Hannah joined HealthTree Foundation as the Lymphoma Education Manager in 2024. She is a Certified Health Education Specialist and is passionate about helping patients feel empowered through education and connection. Before joining HealthTree, Hannah worked in healthcare policy helping patients advocate for better care, research, and funding. Hannah enjoys baking and going to concerts in her free time.

Judith Trotman, FRACP

Professor Judith Trotman is a Senior Staff Specialist and Director of the Clinical Research Unit in the Haematology Department at Concord Repatriation General Hospital in Sydney Australia. She has particular expertise in the management of lymphoid malignancies. Prof. Trotman and her colleagues have built one of the largest clinical research units in Australia for collaboration in a broad portfolio of hematological trials.

Carla Casulo, MD

Carla Casulo, MD, is an Associate Professor of Medicine, and Assistant Director of Cancer Research Training and Education at the Wilmot Cancer Institute. She was awarded her medical degree from the State University of New York in Brooklyn, New York. She later completed her Internship, Residency and Chief Residency in Internal Medicine at Yale University School of Medicine and her Hematology and Oncology Fellowship at Memorial Sloan-Kettering Cancer Center. Dr. Casulo is an international expert and clinician-researcher in all forms of lymphoma, best known for her pivotal work in follicular lymphoma.

Transcript

Follicular Lymphoma Progress in 2024

Related Content